EP2123276
Lyfjasamsetning sem inniheldur pýrasínafleiðu, og aðferð til notkunar á pýrasínafleiðu í samsetningu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.2.2008EP published:
28.11.2012EP application number:
08711267.8
EP translation filed:
23.1.2013Grant published:
15.2.2013EPO information:
European Patent Register
Max expiry date:
13.2.2028Expiry date:
13.2.2027Next due date:
28.2.2027
Title:
PHARMACEUTICAL COMPOSITION COMPRISING PYRAZINE DERIVATIVE, AND METHOD OF USING PYRAZINE DERIVATIVE IN COMBINATION
Timeline
Owner
Name:
Toyama Chemical Co., Ltd.Address:
2-5 Nishishinjuku 3-Chome, 160-0023, Shinjuku-ku, Tokyo, JP
Inventor
Name:
MAEKAWA, MasakoAddress:
Toyama-Shi Toyama, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2007035975Date:
16.2.2007Country:
JP
Classification
Categories:
A61K 31/4965, A61K 31/215, A61P 31/16, A61P 43/00, C07D 241/24
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 23.1.2013
Expires: 13.2.2014
Payer: Árnason Faktor
Number: 7
Paid: 9.1.2014
Expires: 13.2.2015
Payer: Árnason Faktor
Number: 8
Paid: 6.1.2015
Expires: 13.2.2016
Payer: Árnason Faktor
Number: 9
Paid: 5.1.2016
Expires: 13.2.2017
Payer: Árnason Faktor
Number: 10
Paid: 9.1.2017
Expires: 13.2.2018
Payer: Árnason Faktor
Number: 11
Paid: 8.1.2018
Expires: 13.2.2019
Payer: Árnason Faktor
Number: 12
Paid: 9.1.2019
Expires: 13.2.2020
Payer: Árnason Faktor
Number: 13
Paid: 14.1.2020
Expires: 13.2.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 12.1.2021
Expires: 13.2.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 5.1.2022
Expires: 13.2.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 5.1.2023
Expires: 13.2.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 5.1.2023
Expires: 13.2.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 9.1.2024
Expires: 13.2.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 16.1.2025
Expires: 13.2.2026
Payer: Árnason Faktor ehf.
Number: 19
Paid: 13.2.2026
Expires: 13.2.2027
Payer: Árnason Faktor ehf.